NRXS Neuraxis Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: NRXS

Price (delayed)

$7.31

Market cap

$91.8M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.78

Enterprise value

$83.75M

?
Relative Growth: Rel. Growth: 66
Relative Strength: Rel. Strength: 93
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 21
Highlights
Neuraxis's gross profit has soared by 67% YoY and by 25% from the previous quarter
The company's revenue has surged by 65% YoY and by 24% QoQ
Neuraxis's net income has decreased by 7% YoY and by 5% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://neuraxis.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of NRXS

NRXS stock price

How has the Neuraxis stock price performed over time
Intraday
0%
1 week
5.33%
1 month
18.86%
1 year
172.76%
YTD
61.01%
QTD
0%

Financial performance

How have Neuraxis's revenue and profit performed over time
Revenue
$5.32M
Gross profit
$4.55M
Operating income
-$7.68M
Net income
-$7.68M
Gross margin
85.6%
Net margin
-144.4%
Neuraxis's gross profit has soared by 67% YoY and by 25% from the previous quarter
The company's revenue has surged by 65% YoY and by 24% QoQ
The net margin has grown by 35% YoY and by 15% from the previous quarter
The operating margin is up by 35% YoY and by 15% from the previous quarter

Price vs fundamentals

How does NRXS's price correlate with its fundamentals

Growth

What is Neuraxis's growth rate over time

Valuation

What is Neuraxis stock price valuation
P/E
N/A
P/B
13.44
P/S
16.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.75
The EPS has grown by 23% YoY and by 3.7% from the previous quarter
NRXS's equity has soared by 58% year-on-year and by 17% since the previous quarter
NRXS's P/B is 2.6% below its last 4 quarters average of 13.8
The company's revenue has surged by 65% YoY and by 24% QoQ
The stock's P/S is 19% more than its last 4 quarters average of 14.0

Efficiency

How efficient is Neuraxis business performance
The company's return on equity has surged by 71% YoY and by 10% QoQ
Neuraxis's ROA has increased by 44% YoY and by 5% from the previous quarter
The ROS has grown by 35% YoY and by 15% from the previous quarter

Dividends

What is NRXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NRXS.

Financial health

How did Neuraxis financials performed over time
The total assets is up by 41% YoY and by 14% from the previous quarter
The total liabilities is up by 15% YoY and by 9% from the previous quarter
The debt is 96% less than the equity
The debt to equity has plunged by 60% YoY and by 33% from the previous quarter
NRXS's equity has soared by 58% year-on-year and by 17% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.